We're MiLaboratories, the team behind MiXCR and Platforma.Bio. Our tools are cited in thousands of papers and used in the published methods of approved cancer immunotherapies and the COVID vaccines that reached millions of people. 5 of the top 10 pharma companies run discovery programs on Platforma today. Our goal is 10 of 10 by year-end.We're hiring 4–5 engineers in the next 90 days to get us there.ABOUT PLATFORMAMiXCR is the integral standard for immune-repertoire analysis. Platforma.Bio is the operating system we're building on top of it — turning bioinformatics into self-serve, interoperable "blocks" so biologists can move from raw sequencing data to therapeutic candidates without writing pipeline glue code. Our customers are pharma scientists running real discovery programs against real targets. The next paper that cites us could be the next drug.ABOUT THIS ROLEWe made a decision that's reshaping how we hire: we merged our domain-specific teams — desktop, bioinformatics, and data — into a single unit of universal builders.The premise: AI made cross-domain context cheap.
The wall between "the bioinformatician who writes the algorithm" and "the engineer who builds the UI" no longer needs to exist. The bioinformaticians on our team who leaned into engineering, and the engineers who leaned into biology, are now shipping at multiples of what they used to. We need more of those people.This is a senior, full-stack role for engineers who refuse to stay on one side of the biology/software wall.WHAT YOU'LL BUILDBiologic discovery pipelines — end-to-end workflows that take a customer from raw sequencing data to pre-IND therapeutic candidates. Antibody discovery is our anchor; biomarkers, single-cell, and multi-omics extend from there.The Platforma SDK — the toolkit that bioinformaticians use to build new blocks and love. TypeScript and Vue 3 on the frontend, Rust at the core, Tengo (a niche Lua-like workflow DSL — yes, you'll learn it) for orchestration, and Python with Pol